SCHEDULE: Bigger Capital, District 2 Disclose Neuraxis Stake

Investment entities led by Michael Bigger have disclosed significant passive stakes in Neuraxis, INC, collectively owning 6.99% of the common stock.

Summary

• Bigger Capital Fund L P, Bigger Capital Fund GP, LLC, District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and Michael Bigger are the Reporting Persons.
• The filing pertains to Neuraxis, INC's Common Stock, par value $0.001 per share.
• Michael Bigger beneficially owns an aggregate of 689,559 shares, representing 6.99% of the outstanding common stock.
• Bigger Capital Fund L P and Bigger Capital Fund GP, LLC beneficially own 583,998 shares, accounting for 5.92% of the class.
• District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, and District 2 Holdings LLC beneficially own 105,561 shares, representing 1.07% of the class.
• These ownership percentages are calculated based on 9,858,716 shares of Common Stock outstanding as of June 30, 2025, as reported in Neuraxis, INC's Form 10-Q filed on August 12, 2025.
• The filing is a Schedule 13G, indicating that the securities were acquired and are held for passive investment purposes, not to change or influence control of the issuer.
• The reported beneficial ownership excludes shares issuable upon exercise of Warrants due to a 9.99% beneficial ownership limitation.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive stake by a group of investment entities and an individual investor, Michael Bigger, suggests a positive view on Neuraxis, INC's value proposition, indicating potential for future growth or undervaluation.

Positives

• A group of investment entities and an individual investor, Michael Bigger, have disclosed a significant aggregate passive stake of 6.99% in Neuraxis, INC, signaling investor confidence.
• The accumulation of a notable stake by institutional investors can potentially attract further market attention and liquidity to the stock.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance from Neuraxis, INC or the reporting persons regarding the company's future performance or strategic direction.

Industry Context

The accumulation of a significant passive stake by an investment group in Neuraxis, INC suggests a perceived value or potential in the company, which operates in the healthcare or biotechnology sector (implied by the name). Such investments can sometimes precede increased investor interest or strategic engagement within the industry.

Stakeholder Impact

• Shareholders: Increased institutional ownership may provide stability and potentially attract further investor interest, signaling confidence in the company.
• Management: Awareness of a significant passive shareholder group, which could influence future strategic decisions or engagement.

Key Dates

Recommendation

The filing indicates a notable passive investment by Michael Bigger and associated entities, suggesting a positive view on Neuraxis, INC's long-term prospects. However, as a Schedule 13G, it does not provide operational or financial performance details that would warrant a stronger recommendation. Investors should hold and monitor for further developments or operational updates from the company.

Keywords

Neuraxis, common stock, Schedule 13G, beneficial ownership, institutional investor, Michael Bigger, Bigger Capital, District 2 Capital, passive investment